DNA: Ginkgo Bioworks Holdings, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 7 sales totaling $1.34M in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-19 | Coen Steven P. | Officer | $8K | |
| 2026-10-19 | Canton Barry | 10% Owner | $191K | |
| 2026-10-19 | Canton Barry | 10% Owner | $227K | |
| 2026-10-19 | Shetty Reshma P. | Officer | $227K | |
| 2026-10-19 | Shetty Reshma P. | Officer | $191K | |
| 2026-10-19 | Kelly Jason R | Officer | $463K | |
| 2026-10-05 | Coen Steven P. | Officer | $36K |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-30 | 13G amendment | BlackRock, Inc. | 7.70% | SEC |
Institutional ownership (Q2 2026)
182 institutions reported holding $355.06M of Ginkgo Bioworks Holdings, Inc. on Form 13F (175 the quarter before). 27 opened a new position and 19 sold out. Shares held by institutions: +12%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 4,282,903 | $42.44M |
| VIKING GLOBAL INVESTORS LP | 3,577,128 | $35.45M |
| Erste Asset Management GmbH | 2,536,939 | $25.90M |
| BAILLIE GIFFORD & CO | 2,391,649 | $23.70M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,087,293 | $20.69M |
| Anchorage Capital Group, L.L.C. | 1,746,363 | $17.31M |
| Legal & General Group Plc | 1,669,419 | $16.54M |
| STATE STREET CORP | 1,472,370 | $14.59M |
| GEODE CAPITAL MANAGEMENT, LLC | 1,222,016 | $12.11M |
| FORBES J M & CO LLP | 999,911 | $9.91M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.